Tamala P. Bogan
View detailed information about Tamala P. Bogan, including compliance records, violations, and related data.
Person Profile
FDA investigator, Division of Pharmaceutical Quality Operations II.
Documents (12)
- WARNING LETTER · apothecary health solutions/right value drug stores, llc · November 12, 2019
- WARNING LETTER · Acella Pharmaceuticals, LLC · January 7, 2020
- WARNING LETTER · Prime Lab LLC · August 4, 2023
- WARNING LETTER · walfer corporation · March 16, 2020
- WARNING LETTER · Seatex, LLC · October 20, 2023
- WARNING LETTER · Sovereign Pharmaceuticals, LLC · April 22, 2022
- WARNING LETTER · Empower Clinic Services, LLC dba Empower Pharmacy · March 6, 2020
- WARNING LETTER · Sircle Laboratories, LLC · April 26, 2021
- EIR · MMC HEALTHCARE LTD. · March 30, 2024
- 483 · UFAG Laboratorien AG · October 6, 2006
- EIR · UFAG Laboratorien AG · October 9, 2006
- EIR · Strides Pharma Private Limited · April 5, 2024
Related Office
Person Information
Name
Tamala P. Bogan
Title
Director of Investigations Branch
Role
Regulatory Personnel
ID: af87cd07-1e38-459f-94a0-58b5bf5f533c
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.